Date Filed | Type | Description |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/14/2022 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 5.2% stake in Eventbrite, Inc. |
02/14/2022 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 0% stake in Radware Ltd. |
02/14/2022 |
SC 13G
| CADIAN CAPITAL MANAGEMENT, LP reports a 6.7% stake in TCV Acquisition Corp. |
02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2022 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 7.6% stake in Zogenix, Inc. |
02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/12/2021 |
SC 13G
| CADIAN CAPITAL MANAGEMENT, LP reports a 9.5% stake in Zogenix, Inc. |
02/12/2021 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 3.2% stake in Varonis Systems, Inc. |
02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/12/2021 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 0% stake in NanoString Technologies, Inc. |
02/12/2021 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 0% stake in GenMark Diagnostics, Inc. |
02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2020 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 9.5% stake in GenMark Diagnostics, Inc. |
02/13/2020 |
SC 13G
| CADIAN CAPITAL MANAGEMENT, LP reports a 6.2% stake in Varonis Systems, Inc. |
02/13/2020 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 2.7% stake in Portola Pharmaceuticals, Inc. |
02/13/2020 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 4.9% stake in Zogenix, Inc. |
02/13/2020 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 5.2% stake in NanoString Technologies, Inc. |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2019 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 7.4% stake in NanoString Technologies, Inc. |
02/13/2019 |
SC 13G
| CADIAN CAPITAL MANAGEMENT, LP reports a 6.5% stake in Zogenix, Inc. |
02/13/2019 |
SC 13G
| CADIAN CAPITAL MANAGEMENT, LP reports a 9.7% stake in Portola Pharmaceuticals, Inc. |
02/13/2019 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 8.1% stake in Radware Ltd. |
02/13/2019 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 9% stake in GenMark Diagnostics, Inc. |
02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/13/2018 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 9.5% stake in Electronics for Imaging, Inc. |
02/13/2018 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 2.5% stake in Tableau Software, Inc. |
02/13/2018 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 9.2% stake in GenMark Diagnostics, Inc. |
02/13/2018 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a 6.2% stake in Radware Ltd. |
02/13/2018 |
SC 13G/A
| CADIAN CAPITAL MANAGEMENT, LP reports a |
|